Recent findings indicate that inhibiting NF-κB signaling within renal tubular epithelial cells can reduce inflammation and renal fibrosis caused by senescence, which may be a potential strategy for treating CKD (O'Sullivan et al., 2023; Wang et al., 2024). This evidence concerns the gene NFKB1 and renal fibrosis.